Subcutaneous application of gentamicin collagen implants as prophylaxis of surgical site infections in laparoscopic colorectal surgery: A randomized, double-blinded, 3-armed trial
Not Applicable
- Conditions
- T81.4Infection following a procedure, not elsewhere classified
- Registration Number
- DRKS00006239
- Lead Sponsor
- Marienhospital Stuttgart
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 291
Inclusion Criteria
All adult patients scheduled for an elective laparoscopic resection
Exclusion Criteria
known allergic reaction to gentamicin or animal collagen, refusal to participate, expected incompliance or intraoperative conversion to open surgery
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Surgical Site Infection (according definition of CDC) in the first 28 days after surgery, visite by investigator
- Secondary Outcome Measures
Name Time Method incidence of surgical or general complications, the length of hospitalization and the incidence of incisional hernias during study period, check of patient file